Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
In the intricate web of pharmaceutical manufacturing, the strategic selection and reliable sourcing of intermediates are critical for success. 4-Methylsulfanyl-2-[[3-Phenyl-2-(Phenylmethoxycarbonylamino)propanoyl]amino]butanoic acid, widely recognized by its shorthand Cbz-L-Phe-L-Met-OH or Z-Phe-Met-OH (CAS: 13126-07-3), holds significant strategic importance in this context. Its role as a precisely engineered chemical building block directly influences the efficiency of research and development pipelines and the ultimate quality of pharmaceutical products.
The inherent value of Cbz-L-Phe-L-Met-OH lies in its ability to simplify complex synthetic pathways. By providing a pre-formed dipeptide unit with appropriate protecting groups, it reduces the number of steps and potential complications in the synthesis of larger, more complex molecules, particularly peptides. This efficiency translates into faster development cycles and potentially lower manufacturing costs for new drugs. Pharmaceutical companies that prioritize sourcing high-purity (>98%) Cbz-L-Phe-L-Met-OH from reputable suppliers, such as NINGBO INNO PHARMCHEM CO.,LTD., gain a competitive advantage by ensuring the consistency and reliability of their production processes. The availability of this intermediate supports the scalability of drug manufacturing, from early clinical trials to full commercial production.
Furthermore, the specific chemical properties of Z-Phe-Met-OH, including its stability and reactivity profile, are meticulously managed to ensure optimal performance in synthesis. Understanding these 4-methylsulfanyl-2-[[3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]butanoic acid properties allows chemists to design robust and reproducible manufacturing protocols. As the demand for peptide-based therapies and complex organic molecules continues to grow, the strategic importance of intermediates like Cbz-L-Phe-L-Met-OH will only intensify. Manufacturers and suppliers who can consistently deliver this crucial compound are integral partners in the advancement of modern medicine, directly impacting patient access to innovative treatments. Therefore, a focus on sourcing from trusted providers is a key element of any forward-thinking pharmaceutical manufacturing strategy.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
